143 related articles for article (PubMed ID: 19408239)
1. Agar-gelatin hybrid sponge-induced three-dimensional in vitro 'liver-like' HepG2 spheroids for the evaluation of drug cytotoxicity.
Verma P; Verma V; Ray P; Ray AR
J Tissue Eng Regen Med; 2009 Jul; 3(5):368-76. PubMed ID: 19408239
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of agar-gelatin hybrid scaffolds using a novel entrapment method for in vitro tissue engineering applications.
Verma V; Verma P; Kar S; Ray P; Ray AR
Biotechnol Bioeng; 2007 Feb; 96(2):392-400. PubMed ID: 16850454
[TBL] [Abstract][Full Text] [Related]
3. Rat primary hepatocytes show enhanced performance and sensitivity to acetaminophen during three-dimensional culture on a polystyrene scaffold designed for routine use.
Schutte M; Fox B; Baradez MO; Devonshire A; Minguez J; Bokhari M; Przyborski S; Marshall D
Assay Drug Dev Technol; 2011 Oct; 9(5):475-86. PubMed ID: 21675871
[TBL] [Abstract][Full Text] [Related]
4. Engineering liver tissue spheroids with inverted colloidal crystal scaffolds.
Lee J; Cuddihy MJ; Cater GM; Kotov NA
Biomaterials; 2009 Sep; 30(27):4687-94. PubMed ID: 19524294
[TBL] [Abstract][Full Text] [Related]
5. Engineering a scaffold-free 3D tumor model for in vitro drug penetration studies.
Ong SM; Zhao Z; Arooz T; Zhao D; Zhang S; Du T; Wasser M; van Noort D; Yu H
Biomaterials; 2010 Feb; 31(6):1180-90. PubMed ID: 19889455
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of drug toxicity with hepatocytes cultured in a micro-space cell culture system.
Nakamura K; Mizutani R; Sanbe A; Enosawa S; Kasahara M; Nakagawa A; Ejiri Y; Murayama N; Miyamoto Y; Torii T; Kusakawa S; Yamauchi J; Fukuda M; Yamazaki H; Tanoue A
J Biosci Bioeng; 2011 Jan; 111(1):78-84. PubMed ID: 20837398
[TBL] [Abstract][Full Text] [Related]
7. A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies.
Ramaiahgari SC; den Braver MW; Herpers B; Terpstra V; Commandeur JN; van de Water B; Price LS
Arch Toxicol; 2014 May; 88(5):1083-95. PubMed ID: 24599296
[TBL] [Abstract][Full Text] [Related]
8. Alginate based 3D hydrogels as an in vitro co-culture model platform for the toxicity screening of new chemical entities.
Lan SF; Starly B
Toxicol Appl Pharmacol; 2011 Oct; 256(1):62-72. PubMed ID: 21839104
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a galactose-carrying gelatin sponge for hepatocytes culture and transplantation.
Hong SR; Lee YM; Akaike T
J Biomed Mater Res A; 2003 Dec; 67(3):733-41. PubMed ID: 14613220
[TBL] [Abstract][Full Text] [Related]
10. Application of multiple parallel perfused microbioreactors and three-dimensional stem cell culture for toxicity testing.
Cui ZF; Xu X; Trainor N; Triffitt JT; Urban JP; Tirlapur UK
Toxicol In Vitro; 2007 Oct; 21(7):1318-24. PubMed ID: 17640847
[TBL] [Abstract][Full Text] [Related]
11. Micropatterned organoid culture of rat hepatocytes and HepG2 cells.
Mori R; Sakai Y; Nakazawa K
J Biosci Bioeng; 2008 Sep; 106(3):237-42. PubMed ID: 18929998
[TBL] [Abstract][Full Text] [Related]
12. Formation and characterization of three dimensional human hepatocyte cell line spheroids on chitosan matrix for in vitro tissue engineering applications.
Verma P; Verma V; Ray P; Ray AR
In Vitro Cell Dev Biol Anim; 2007; 43(10):328-37. PubMed ID: 17952520
[TBL] [Abstract][Full Text] [Related]
13. The controlled presentation of TGF-beta1 to hepatocytes in a 3D-microfluidic cell culture system.
Zhang C; Chia SM; Ong SM; Zhang S; Toh YC; van Noort D; Yu H
Biomaterials; 2009 Aug; 30(23-24):3847-53. PubMed ID: 19394078
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of liver progenitor cell line to functional organotypic cultures in 3D nanofibrillar cellulose and hyaluronan-gelatin hydrogels.
Malinen MM; Kanninen LK; Corlu A; Isoniemi HM; Lou YR; Yliperttula ML; Urtti AO
Biomaterials; 2014 Jun; 35(19):5110-21. PubMed ID: 24698520
[TBL] [Abstract][Full Text] [Related]
15. Functional three-dimensional HepG2 aggregate cultures generated from an ultrasound trap: comparison with HepG2 spheroids.
Liu J; Kuznetsova LA; Edwards GO; Xu J; Ma M; Purcell WM; Jackson SK; Coakley WT
J Cell Biochem; 2007 Dec; 102(5):1180-9. PubMed ID: 17440959
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and functional changes of rat liver spheroids during spheroid formation and maintenance in culture: II. nitric oxide synthesis and related changes.
Xu J; Ma M; Purcell WM
J Cell Biochem; 2003 Dec; 90(6):1176-85. PubMed ID: 14635191
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and functional changes of rat liver spheroids during spheroid formation and maintenance in culture: I. morphological maturation and kinetic changes of energy metabolism, albumin synthesis, and activities of some enzymes.
Ma M; Xu J; Purcell WM
J Cell Biochem; 2003 Dec; 90(6):1166-75. PubMed ID: 14635190
[TBL] [Abstract][Full Text] [Related]
18. Reprint of: A three-dimensional in vitro HepG2 cells liver spheroid model for genotoxicity studies.
Shah UK; Mallia JO; Singh N; Chapman KE; Doak SH; Jenkins GJS
Mutat Res Genet Toxicol Environ Mutagen; 2018 Oct; 834():35-41. PubMed ID: 30173862
[TBL] [Abstract][Full Text] [Related]
19. In vitro toxicity testing of nanoparticles in 3D cell culture.
Lee J; Lilly GD; Doty RC; Podsiadlo P; Kotov NA
Small; 2009 May; 5(10):1213-21. PubMed ID: 19263430
[TBL] [Abstract][Full Text] [Related]
20. 3D hepatocyte monolayer on hybrid RGD/galactose substratum.
Du Y; Chia SM; Han R; Chang S; Tang H; Yu H
Biomaterials; 2006 Nov; 27(33):5669-80. PubMed ID: 16904177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
